Clinical Trial Update: New Markers for Minimal Residual Disease in Acute Lymphoblastic Leukemia

View source ↗

Summary

A clinical trial update from Assiut University investigates new markers for detecting minimal residual disease in acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Assiut University | Conditions: Acute Lymphoblastic Leukemia | Status: UNKNOWN